Enovis’ reverse glenoid system earns FDA clearance

Enovis earned FDA 510(k) clearance for its AltiVate reverse glenoid system, the devicemaker said July 12.

Advertisement

The clearance expands the company’s glenoid implant offering of the AltiVate reverse shoulder system to include modular, augmented baseplates, according to a news release.

Mark Frankle, MD, performed the first case with the new system at Tampa (Fla.) General Hospital on July 8.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.